» Articles » PMID: 34673516

Bioprosthetic Aortic Valve Degeneration: a Review from a Basic Science Perspective

Overview
Date 2021 Oct 21
PMID 34673516
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The increase in the prevalence of aortic stenosis due to an aging population has led to an increasing number of surgical aortic valve replacements. Over the past 20 years, there has been a major shift in preference from mechanical to bioprosthetic valves. However, despite efforts, there is still no "ideal" bioprosthesis. It is crucial to understand the structure, biology, and function of native heart valves to design more intelligent, strong, durable, and physiological heart valve tissues.

Methods: A comprehensive review of the literature was performed to identify articles reporting the basic mechanisms of bioprosthetic valve dysfunction and the biology of native valve cells. Searches were run in PubMed, MEDLINE® (the Medical Literature Analysis and Retrieval System Online), and Google Scholar. Terms for subject heading and keywords search included "biological heart valve dysfunction", "bioprosthesis dysfunction", "bioprosthesis degeneration", and "tissue heart valves".

Results: All the relevant findings are summarized in the appropriate subsections. Structural dysfunction is a logical and expected consequence of the chemical, mechanical, and immunological processes that occur during fixation, manufacture, and implantation.

Conclusion: Biological prosthesis valve dysfunction is a clinically significant process. It has become a major issue considering the growing rate of bioprosthesis implantation and improved long-term patient survival. Understanding bioprosthetic aortic valve degeneration from a basic science perspective is a key point to improve technologic advances and specifications that lead to a new generation of bioprostheses.

Citing Articles

Contemporary Multi-modality Imaging of Prosthetic Aortic Valves.

Abadie B, Wang T Rev Cardiovasc Med. 2025; 26(1):25339.

PMID: 39867176 PMC: 11759978. DOI: 10.31083/RCM25339.


Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management.

Bismee N, Javadi N, Khedr A, Omar F, Awad K, Abbas M J Cardiovasc Dev Dis. 2024; 11(12).

PMID: 39728274 PMC: 11676755. DOI: 10.3390/jcdd11120384.


Lipoprotein (a) and lipid-lowering treatment from the perspective of a cardiac surgeon. An impact on the prognosis in patients with aortic valve replacement and after heart transplantation.

Surma S, Zembala M, Okopien B, Banach M Int J Cardiol Cardiovasc Risk Prev. 2024; 22:200297.

PMID: 38962113 PMC: 11219948. DOI: 10.1016/j.ijcrp.2024.200297.


Thrombocytopenia after Aortic Valve Replacement Using Sutureless Valves.

Kim M, Lee S, Lee J, Joo S, Park Y, Kim K J Chest Surg. 2024; 57(4):371-379.

PMID: 38528757 PMC: 11240101. DOI: 10.5090/jcs.23.167.


Albumin Thiolation and Oxidative Stress Status in Patients with Aortic Valve Stenosis.

Savini C, Tenti E, Mikus E, Eligini S, Munno M, Gaspardo A Biomolecules. 2023; 13(12).

PMID: 38136584 PMC: 10742097. DOI: 10.3390/biom13121713.


References
1.
Vesely I . Heart valve tissue engineering. Circ Res. 2005; 97(8):743-55. DOI: 10.1161/01.RES.0000185326.04010.9f. View

2.
Broom N, Thomson F . Influence of fixation conditions on the performance of glutaraldehyde-treated porcine aortic valves: towards a more scientific basis. Thorax. 1979; 34(2):166-76. PMC: 471033. DOI: 10.1136/thx.34.2.166. View

3.
Johnston D, Soltesz E, Vakil N, Rajeswaran J, Roselli E, Sabik 3rd J . Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015; 99(4):1239-47. PMC: 5132179. DOI: 10.1016/j.athoracsur.2014.10.070. View

4.
Walker G, Masters K, Shah D, Anseth K, Leinwand L . Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res. 2004; 95(3):253-60. DOI: 10.1161/01.RES.0000136520.07995.aa. View

5.
Golomb G, Schoen F, Smith M, Linden J, Dixon M, Levy R . The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol. 1987; 127(1):122-30. PMC: 1899585. View